Health Catalyst, Inc. (NASDAQ:HCAT) Given Consensus Recommendation of “Hold” by Analysts

Health Catalyst, Inc. (NASDAQ:HCAT) has been given a consensus recommendation of “Hold” by the thirteen analysts that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and four have assigned a buy rating to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $2.7955.

A number of equities research analysts have issued reports on HCAT shares. Raymond James Financial set a $3.00 target price on shares of Health Catalyst in a research note on Friday, March 13th. Stephens cut their price objective on Health Catalyst from $3.50 to $2.00 and set an “equal weight” rating for the company in a report on Friday, March 13th. Weiss Ratings reissued a “sell (e+)” rating on shares of Health Catalyst in a research report on Monday, December 29th. Cantor Fitzgerald lowered their target price on Health Catalyst from $4.00 to $3.00 and set a “neutral” rating on the stock in a research note on Friday, March 13th. Finally, Canaccord Genuity Group lowered their target price on Health Catalyst from $5.00 to $2.00 and set a “buy” rating on the stock in a research note on Friday, March 13th.

Institutional Investors Weigh In On Health Catalyst

Several large investors have recently made changes to their positions in the company. First Light Asset Management LLC lifted its stake in shares of Health Catalyst by 9.9% in the third quarter. First Light Asset Management LLC now owns 13,436,220 shares of the company’s stock worth $38,293,000 after buying an additional 1,206,039 shares during the last quarter. Vanguard Group Inc. grew its stake in Health Catalyst by 2.9% in the 3rd quarter. Vanguard Group Inc. now owns 4,295,691 shares of the company’s stock valued at $12,243,000 after buying an additional 119,117 shares during the last quarter. Whetstone Capital Advisors LLC grew its stake in Health Catalyst by 0.5% in the 4th quarter. Whetstone Capital Advisors LLC now owns 3,750,377 shares of the company’s stock valued at $8,963,000 after buying an additional 19,027 shares during the last quarter. Nepsis Inc. raised its holdings in Health Catalyst by 26.6% in the 4th quarter. Nepsis Inc. now owns 1,915,794 shares of the company’s stock worth $4,579,000 after acquiring an additional 402,762 shares during the period. Finally, Geode Capital Management LLC raised its holdings in Health Catalyst by 11.4% in the 2nd quarter. Geode Capital Management LLC now owns 1,662,455 shares of the company’s stock worth $6,269,000 after acquiring an additional 169,580 shares during the period. Institutional investors own 85.00% of the company’s stock.

Health Catalyst Trading Up 1.2%

NASDAQ:HCAT opened at $1.23 on Friday. The stock has a market cap of $90.52 million, a PE ratio of -0.48 and a beta of 1.76. Health Catalyst has a fifty-two week low of $1.04 and a fifty-two week high of $5.06. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.89 and a quick ratio of 1.89. The stock’s 50-day moving average is $1.93 and its two-hundred day moving average is $2.48.

Health Catalyst (NASDAQ:HCAT) last posted its quarterly earnings results on Thursday, March 12th. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.02). Health Catalyst had a negative return on equity of 4.30% and a negative net margin of 57.20%.The company had revenue of $74.68 million during the quarter, compared to analysts’ expectations of $73.99 million. As a group, equities research analysts forecast that Health Catalyst will post -0.33 earnings per share for the current fiscal year.

Health Catalyst Company Profile

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.